DexCom (DXCM) Tops Q3 EPS by 4c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- Nasdaq leads Wall Street gains as SpaceX, Super Micro boost AI sentiment
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- SpaceX, Tesla shares rise after Musk says committees exploring possible merger
- Brent falls as Iran's president discusses mediation with Pakistani army chief
- Abbott plans to spin off its nutrition unit as a standalone public company
- Alphabet shares drop ahead of earnings next week
- Nasdaq leads Wall Street gains as SpaceX, Super Micro boost AI sentiment
- Crude Inventory Fell 3.06 Million Barrels Last Week - EIA
- US orders diplomats to depart Saudi Arabia amid Houthi strikes
Dexcom Reports Third Quarter 2022 Financial Results
October 27, 2022 4:03 PM EDTSAN DIEGO--(BUSINESS WIRE)-- DexCom, Inc. (Nasdaq: DXCM) today reported its financial results as of and for the quarter ended September 30, 2022.
Third Quarter 2022 Financial Highlights:
Revenue grew 18% versus the same quarter of the prior year to $769.6 million on a reported basis and 20% on an organic1 basis. U.S. revenue growth of 17% and international revenue growth of 22% on a reported basis. International revenue growth was 28% on an organic1 basis. GAAP operating income of $147.5 million or 19.2% of revenue, an increase of 100 basis points compared to the third... More


